The stock rallied 5% to Rs 732 on Thursday, extending its Wednesday's 2% gain on the BSE, after the company announced the acquisition of Sandoz's generic business in the US for $900 million.
from Latest News https://ift.tt/2Nqpk3a
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd
Home
Business
Business News
Business Standard
Latest News
Aurobindo Pharma gains 5% on acquisition of Sandoz's US business
0 comments: